Publications
-
Lambru G., Benemei S., Andreou A.P., Luciani M., Serafini G., Maassen van den Brink A. Martelletti P. Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine. Pain Ther . DOI: 10.1007/s40122-020-00220-1
-
Lloyd, J. O., K. I. Chisholm, B. Oehle, M. G. Jones, B. N. Okine, A. Al-Kaisy, G. Lambru, S. B. McMahon and A. P. Andreou. "Cortical Mechanisms of Single-Pulse Transcranial Magnetic Stimulation in Migraine." Neurotherapeutics. DOI: 10.1007/s13311-020-00879-6
-
Summ, O., A. P. Andreou, S. Akerman, P. R. Holland, J. Hoffmann and P. J. Goadsby. "Differential actions of indomethacin: clinical relevance in headache." Pain. DOI: 10.1097/j.pain.0000000000002032
-
Alstadhaug, K. B., H. K. Ofte, K. I. Muller and A. P. Andreou. "Sudden Caffeine Withdrawal Triggers Migraine-A Randomized Controlled Trial." Front Neurol 11: 1002 DOI: 10.3389/fneur.2020.01002
-
Andreou, A. P., C. Leese, R. Greco, C. Demartini, E. Corrie, D. Simsek, A. Zanaboni, K. Koroleva, J. O. Lloyd, G. Lambru, C. Doran, O. Gafurov, E. Seward, R. Giniatullin, C. Tassorelli and B. Davletov. "Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine." Neurotherapeutics. DOI: 10.1007/s13311-020-00967-7
-
A.P. Andreou, M Fuccaro, G Lambru. The role of erenumab in the treatment of migraine. Ther Adv Neurol Disord. 2020; 13: 1756286420927119. DOI: 10.1177/1756286420927119
-
J. C. A. Edvinsson, A. Viganò, A. Alekseeva, E. Alieva, R. Arruda, C. De Luca, N. D’Ettore, I. Frattale, M. Kurnukhina, N. Macerola, E. Malenkova, M. Maiorova, A. Novikova, P. Řehulka, V. Rapaccini, O. Roshchina, G. Vanderschueren, L. Zvaune, A. P. Andreou, K. A. Haanes. The fifth cranial nerve in headaches. On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS), J Headache Pain. 2020; 21(1): 65 DOI: 10.1186/s10194-020-01134-1
-
G Lambru, B Hill, M Murphy, I Tylova, A.P. Andreou. A prospective real-world analysis of erenumab in refractory chronic migraine. J Headache Pain. 2020; 21(1): 61 DOI: 10.1186/s10194-020-01127-0
-
Andreou, A.P. and L. Edvinsson. Mechanisms of migraine as a chronic evolutive condition. J Headache Pain, 2019. 20(1): p. 117. DOI: 10.1186/s10194-019-1066-0
-
Alstadhaug, K.B. and A.P. Andreou. Caffeine and Primary (Migraine) Headaches-Friend or Foe? Front Neurol, 2019. 10: p. 1275. DOI: 10.3389/fneur.2019.01275
-
Straube, A. and A.P. Andreou. Correction to: Primary headaches during lifespan. J Headache Pain, 2019. 20(1): p. 71. DOI: 10.1186/s10194-019-1025-9
-
Lambru, G., A. P. Andreou, M. Guglielmetti and P. Martelletti. Emerging drugs for migraine treatment: an update. Expert Opin Emerg Drugs, 2018. 23(4): p. 301-318. DOI: 10.1080/14728214.2018.1552939
-
Andreou, A. P., M. Trimboli, A. Al-Kaisy, M. Murphy, S. Palmisani, C. Fenech, T. Smith and G. Lambru. Prospective real-world analysis of OnabotulinumtoxinA in chronic migraine post-National Institute for Health and Care Excellence UK technology appraisal. Eur J Neurol, 2018. 25(8): p. 1069-e83. DOI: 10.1186/s10194-020-01127-0
-
Trimboli, M., A. Al-Kaisy, A. P. Andreou, M. Murphy and G. Lambru. Non-invasive vagus nerve stimulation for the management of refractory primary chronic headaches: A real-world experience. Cephalalgia, 2018. 38(7): p. 1276-1285. DOI: 10.1177/0333102417731349
-
Lambru, G., A. P. Andreou, E. R. de la Torre and P. Martelletti. Tackling the perils of unawareness: the cluster headache case. J Headache Pain, 2017. 18(1): p. 49. DOI: 10.1186/s10194-017-0757-7
-
Torres-Perez, J. V., P. Santha, A. Varga, P. Szucs, J. Sousa-Valente, B. Gaal, M. Sivado, A. P. Andreou, S. Beattie, B. Nagy, K. Matesz, C. A. JS, G. Jancso and I. Nagy. Phosphorylated Histone 3 at Serine 10 Identifies Activated Spinal Neurons and Contributes to the Development of Tissue Injury-Associated Pain. Sci Rep, 2017. 7: p. 41221. DOI: 10.1038/srep41221
-
Jones, M. G., A. P. Andreou, S. B. McMahon and D. Spanswick. Pharmacology of reflex blinks in the rat: a novel model for headache research. J Headache Pain, 2016. 17(1): p. 96. DOI: 10.1186/s10194-016-0686-x
-
Andreou, A. P., P. R. Holland, S. Akerman, O. Summ, J. Fredrick and P. J. Goadsby. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain, 2016. 139(Pt 7): p. 2002-14.DOI: 10.1007/s13311-020-00879-6
-
Andreou, A. P., M. Efthymiou, Y. Yu, H. R. Watts, F. H. Noormohamed, D. Ma, D. A. Lane and J. T. Crawley. Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke. PLoS One, 2015. 10(4): p. e0122410. DOI: 10.1371/journal.pone.0122410
-
Andreou, A. P., P. R. Holland, M. P. Lasalandra and P. J. Goadsby. Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors. Pain, 2015. 156(3): p. 439-50. DOI: 10.1097/01.j.pain.0000460325.25762.c0
-
Hoffmann, J., W. Supronsinchai, S. Akerman, A. P. Andreou, C. J. Winrow, J. Renger, R. Hargreaves and P. J. Goadsby. Evidence for orexinergic mechanisms in migraine. Neurobiol Dis, 2015. 74: p. 137-43. DOI: 10.1016/j.nbd.2014.10.022
-
Nagy, I., D. Friston, J. S. Valente, J. V. Torres Perez and A. P. Andreou. Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channel. Prog Drug Res, 2014. 68: p. 39-76. DOI: 10.1007/978-3-0348-0828-6_2
-
Woldeamanuel, Y.W., A.P. Andreou, and R.P. Cowan. Prevalence of migraine headache and its weight on neurological burden in Africa: a 43-year systematic review and meta-analysis of community-based studies. J Neurol Sci, 2014. 342(1-2): p. 1-15. DOI: 10.1016/j.jns.2014.04.019
-
Park, J., H. Moon, S. Akerman, P. R. Holland, M. P. Lasalandra, A. P. Andreou, M. D. Ferrari, A. M. van den Maagdenberg and P. J. Goadsby. Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: a Fos protein study. Neurobiol Dis, 2014. 64: p. 1-7. DOI: 10.1016/j.nbd.2013.12.004
-
Sousa-Valente, J., A. P. Andreou, L. Urban and I. Nagy. Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics. Br J Pharmacol, 2014. 171(10): p. 2508-27. DOI: 10.1111/bph.12532
-
Varga, A., A. Jenes, T. H. Marczylo, J. Sousa-Valente, J. Chen, J. Austin, S. Selvarajah, F. Piscitelli, A. P. Andreou, A. H. Taylor, F. Kyle, M. Yaqoob, S. Brain, J. P. White, L. Csernoch, V. Di Marzo, L. Buluwela and I. Nagy. Anandamide produced by Ca(2+)-insensitive enzymes induces excitation in primary sensory neurons. Pflugers Arch, 2014. 466(7): p. 1421-35. DOI: s00424-013-1360-7
-
Holland, P. R., S. Akerman, A. P. Andreou, N. Karsan, J. A. Wemmie and P. J. Goadsby. Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura. Ann Neurol, 2012. 72(4): p. 559-63. DOI: 10.1002/ana.23653
-
Hoffmann, J., W. Supronsinchai, A. P. Andreou, O. Summ, S. Akerman and P. J. Goadsby. Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system. Pain, 2012. 153(11): p. 2226-32. DOI: 10.1016/j.pain.2012.07.006
-
Sprenger, T., C. L. Seifert, M. Valet, A. P. Andreou, A. Foerschler, C. Zimmer, D. L. Collins, P. J. Goadsby, T. R. Tolle and M. M. Chakravarty. Assessing the risk of central post-stroke pain of thalamic origin by lesion mapping. Brain, 2012. 135(Pt 8): p. 2536-45. DOI: 10.1093/brain/aws153
-
Andreou, A.P. and P.J. Goadsby. Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway. Cephalalgia, 2011. 31(13): p. 1343-58. DOI: 10.1111/j.1538-7836.2011.04292.x
-
Mathew, R., A. P. Andreou, L. Chami, A. Bergerot, A. M. van den Maagdenberg, M. D. Ferrari and P. J. Goadsby. Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse. Cephalalgia, 2011. 31(13): p. 1368-80. DOI: 10.1177/0333102411418847
-
Andreou, A.P. and J.T. Crawley. Thrombomodulin analogues for the treatment of ischemic stroke. J Thromb Haemost, 2011. 9(6): p. 1171-3. DOI: 10.1177/0333102411418259
-
Summ, O., A. P. Andreou, S. Akerman and P. J. Goadsby. A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches. J Headache Pain, 2010. 11(6): p. 477-83. DOI: 10.1007/s10194-010-0263-7
-
Summ, O., A. R. Charbit, A. P. Andreou and P. J. Goadsby. Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. Brain, 2010. 133(9): p. 2540-8. DOI: 10.1093/brain/awq224
-
Andreou, A. P., O. Summ, A. R. Charbit, M. Romero-Reyes and P. J. Goadsby. Animal models of headache: from bedside to bench and back to bedside. Expert Rev Neurother, 2010. 10(3): p. 389-411. DOI: 10.1586/ern.10.16
-
Andreou, A.P., K.G. Shields, and P.J. Goadsby. GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus. Neurobiol Dis, 2010. 37(2): p. 314-23. DOI: 10.1016/j.nbd.2009.10.007
-
Andreou, A.P. and P.J. Goadsby. Therapeutic potential of novel glutamate receptor antagonists in migraine. Expert Opin Investig Drugs, 2009. 18(6): p. 789-803. DOI: 10.1517/13543780902913792
-
Andreou, A.P., P.R. Holland, and P.J. Goadsby. Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation. Br J Pharmacol, 2009. 157(3): p. 464-73. DOI: 10.1111/j.1476-5381.2009.00142.x
-
Goadsby, P. J., A. R. Charbit, A. P. Andreou, S. Akerman and P. R. Holland. Neurobiology of migraine. Neuroscience, 2009. 161(2): p. 327-41. DOI: 10.1016/j.neuroscience.2009.03.019
-
Andreou, A., N. Dabarakis, A. Kagiava, E. K. Kosmidis, A. Geronikaki and G. Theophilidis. Assessing the effects of three dental impression materials on the isolated sciatic nerve of rat and frog. Toxicol In Vitro, 2007. 21(1): p. 103-8. DOI: 10.1016/j.tiv.2006.07.014
Book chapters
-
Animal Models of Migraine. Andreou AP, Oshinksy ML. Springer International Publishing Switzerland 2015 Ashina M., Geppetti P. (eds.), Pathophysiology of Headaches: From Molecule to Man, Headache, DOI 10.1007/978-3-319-15621-7_2
-
Trigeminal Mechanisms of Nociception. Andreou AP, Edvinsson L. Springer International Publishing Switzerland 2020 Lambru G., Lanteri-Minet M. (eds.), Neuromodulation in Headache and Facial Pain Management; Principles, Rationale and Clinical Data DOI 10.1007/978-3-030-14121-9